MUMBAI, India, Sept. 14 -- Intellectual Property India has published a patent application (202611088117 A) filed by Chitkara University on July 19, 2026, for Proliposomal Composition Comprising Asparagus Racemosus Extract And Oral Dosage Forms Thereof For Management Of Polycystic Ovary Syndrome.
Inventors include Souptik Adak; Rohit Sharma; Dr. Poonam Negi; Dr. Thakur Gurjeet Singh; and Dr. Sonia Dhiman.
The application for the patent was published on September 11, 2026, under issue no. 37/2026.
Abstract: The present invention relates to a proliposomal composition comprising Asparagus racemosus extract and oral dosage forms thereof for management of polycystic ovary syndrome (PCOS). The composition comprises Asparagus racemosus extract, at least one phospholipid, at least one surfactant, and at least one carrier, wherein the composition forms a liposomal dispersion upon contact with an aqueous medium. The proliposomal system enhances solubility, stability, gastrointestinal absorption, and bioavailability of bioactive constituents present in the extract. The composition may be formulated as sachets, capsules, tablets, granules, powders for reconstitution, suspensions, or combinations thereof and is useful for management of PCOS and associated reproductive, hormonal, and metabolic disorders. Reference
Disclaimer: Curated by HT Syndication.
